Tilray (NASDAQ:TLRY) Stock Price Down 0.1% – Time to Sell?

Tilray Inc (NASDAQ:TLRY)’s share price fell 0.1% during trading on Monday . The company traded as low as $1.58 and last traded at $1.59. 3,181,930 shares changed hands during mid-day trading, a decline of 87% from the average session volume of 24,956,004 shares. The stock had previously closed at $1.59.

Wall Street Analyst Weigh In

Separately, Roth Mkm decreased their price objective on shares of Tilray from $2.00 to $1.75 and set a “neutral” rating on the stock in a report on Friday, October 11th.

Tilray Trading Down 1.8 %

The stock has a market capitalization of $1.52 billion, a PE ratio of -6.26 and a beta of 2.13. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.47 and a quick ratio of 1.57. The company’s 50 day moving average price is $1.73 and its two-hundred day moving average price is $1.80.

Tilray (NASDAQ:TLRY) last announced its quarterly earnings data on Thursday, October 10th. The company reported ($0.04) EPS for the quarter, hitting analysts’ consensus estimates of ($0.04). Tilray had a negative return on equity of 2.00% and a negative net margin of 26.79%. The firm had revenue of $200.00 million for the quarter, compared to the consensus estimate of $218.70 million. During the same quarter last year, the business posted ($0.10) earnings per share. The firm’s revenue was up 13.0% compared to the same quarter last year. As a group, analysts expect that Tilray Inc will post -0.14 earnings per share for the current year.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the stock. Prospect Financial Services LLC acquired a new stake in shares of Tilray during the second quarter worth about $26,000. Signature Estate & Investment Advisors LLC acquired a new position in shares of Tilray during the second quarter worth about $29,000. Jeppson Wealth Management LLC purchased a new stake in shares of Tilray during the second quarter worth approximately $33,000. Vanguard Capital Wealth Advisors acquired a new stake in Tilray in the second quarter valued at approximately $34,000. Finally, HBK Sorce Advisory LLC purchased a new position in Tilray in the first quarter worth approximately $37,000. Institutional investors and hedge funds own 9.35% of the company’s stock.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.